A Danish company that’s the sole producer of the only approved vaccine has sold nearly all its supplies to the US, and it won’t be making new doses until 2023.
After the Supreme Court’s Dobbs ruling, more people are seeking to get their tubes tied—assuming they can find a sympathetic doctor.
Doctors will be cautious about offering any treatment that could be regarded as an illegal termination—forcing patients to seek out-of-state care.
Two new studies found genetic mutations that cause severe immune deficiencies are common in some remote populations, leaving them highly vulnerable to viruses.
The open science movement pushes for making scientific knowledge quickly accessible to all. But a new paper warns that speed can come at a cost.
A woman grew up without her left temporal lobe, which highlights how amazingly plastic the brain is.
Sanctions and boycotts following the invasion of Ukraine have curtailed the export of nearly every product—except medicines. That’s up to drugmakers.
Hundreds of trials have been disrupted in the medical research hub. Some patients are at risk of losing their last chance at survival.
The island nation’s government joins several other European countries in dropping Covid restrictions—but not everyone is sure the timing’s right.